More Japanese moves to encourage generics

26 May 2009

Japan's Chuikyo (Central Social Insurance Medical Council) has approved the Ministry of Health, Labor and Welfare's plan to strongly urge  medical facilities and pharmacies to comply with the obligation to make  efforts to use generic drugs. This was stipulated in the medical  treatment rules for health insurance physicians and pharmacists under  the ministry's ordinance upon the changes of the 2008 medical fee  revision, through local health authorities because some physicians and  pharmacists are declining to use generic drugs, according to MHLW survey  data (Marketletter May 4).

In addition, the MHLW plans to call for insurers to provide the insured  with "a wish card for generic drugs," pamphlets/leaflets on generic  drugs, and for medical facilities to share the lists of copy products  which are stocked by pharmacies in their community. The MHLW will also  publish data on its examinations/tests for the quality of copy versions  if some concerns about the these are raised, deploy a specific panel for  promoting the use of generics, consisting of civil servants,  drugmakers, physicians, pharmacists and consumers in each prefecture  (already established in 29 regions), and to hold seminars on the  quality of copy medicines.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight